G

GE Healthcare

Imaging, monitoring, and healthcare IT solutions

SAP Platform Leader

Full-TimePosted on 7/28/2026Deadline 8/17/26
PLN408k - PLN561k/yr+ Performance Bonus
Expert
Bachelor's
Bengaluru, Karnataka, India
In Person
Operations & LogisticsSupply Chain Management

About the job

Requirements
  • Strong business analysis, problem-solving, and strategic thinking capabilities, with the ability to translate complex challenges into actionable outcomes.
  • Proven ability to lead, organize, and motivate diverse, cross-functional teams in complex environments, providing clear direction and confidence.
  • Extensive experience managing Application Management Services providers, governance, and offshore delivery models.
  • Financial acumen and experience managing both capital expenditure and operating expenditure budgets.
  • Experience developing talent, coaching, and building high-performing teams.
  • Demonstrated involvement in multiple end-to-end SAP implementation programmes; hands-on full-lifecycle delivery experience is highly desirable.
  • Success operating within large, distributed, matrixed IT organizations and overseeing application development and support functions.
  • Understanding of integration approaches between SAP and external enterprise systems, including middleware, APIs, and interfaces.
  • Knowledge of global SAP ERP deployment methodologies, ideally within regulated industries.
  • A bachelor's degree in Computer Science, Information Technology, or a STEM discipline, or equivalent experience.
  • At least 15 years of progressive IT experience, preferably within MedTech, Life Sciences, or similarly regulated industries.
  • At least 10 years of ERP experience with strong working knowledge of SAP ECC.
  • At least 3 years in a Service Operations or IT Service Delivery leadership role with accountability for outcomes, service-level agreements, and vendor performance.
Responsibilities
  • Act as the primary point of contact for business and IT leadership on ERP service delivery matters and communicate performance transparently.
  • Build and maintain relationships with cross-functional business leaders and IT stakeholders to ensure alignment and collaboration.
  • Translate business priorities and strategies into IT roadmaps supporting organizational objectives.
  • Lead and develop a global team of IT professionals, fostering a high-performance culture, capability building, and continuous learning.
  • Lead the global ERP RUN organization and ensure effective Incident, Change, and Service Request management.
  • Own the SAP data strategy, governance, and operating model, ensuring data quality, consistency, integrity, and compliance across SAP landscapes.
  • Oversee operational support of SAP integration platforms, middleware, APIs, EDI, and interface services.
  • Drive continuous improvement aligned with service-level agreements, root-cause elimination, and value-added service delivery.
  • Provide technical and operational leadership to IT Operations teams and ensure end-to-end issue resolution.
  • Manage external service providers, including contract governance, statements of work, and performance tracking.
  • Ensure compliance with regulatory, quality, cybersecurity, healthcare, and GxP requirements, including SOX and ITGC standards.
  • Govern system architecture standards and oversee business continuity, risk management, and audit readiness.
  • Establish the new SAP RISE with HANA landscape, including correct system setup, as part of the S/4HANA transformation.
  • Design and develop business roles aligned with defined personas.
  • Support all testing phases, including dress rehearsals.
Desired Qualifications
  • Hands-on experience across full-lifecycle SAP implementation delivery.
  • Experience in SAP S/4HANA transformation or migration programmes.
  • Experience within pharmaceutical, MedTech, Life Sciences, or similarly regulated industries.

About the company

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 orders rose 11% and backlog reached a record $23.9 billion.
  • CareIntellect for Operations launched September 2026 with Duke Health and Queen's Health Systems.
  • CE mark and FDA progress for Photonova Spectra expand 2026-2027 commercial momentum.

What critics are saying

  • FDA logged multiple 2026 Class 2 recalls, including AW Server and telemetry systems.
  • Patient Care Solutions remained weak in Q2 2026; management is reviewing a sale.
  • SOFIE closes only after 2027 regulatory approvals; PET supply integration can slip badly.

What makes GE Healthcare unique

  • GE HealthCare combines imaging hardware, radiopharmaceuticals, and workflow software across hospitals.
  • Photonova Spectra and Vivid 2026 show premium innovation plus AI-enabled clinical automation.
  • SOFIE's 21 cyclotrons extend GE HealthCare into radiotracer manufacturing, not just scanners.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Tuition Reimbursement
  • Relocation Assistance

Company News

Associated Press
Oct 20th, 2026
GE HealthCare launches five-institution global trial of StarGuide GX theranostics SPECT/CT system

GE HealthCare has launched a clinical evaluation program for StarGuide GX, its next-generation digital 4D SPECT/CT system. Five institutions across three continents will take part. They are Hadassah Medical Center and Rambam Health Care Campus in Israel, Mayo Clinic in the US, Oncopole Claudius Regaud in France, and Peking University First Hospital in China. Each will assess image quality, quantitative performance, dynamic imaging, and workflow, and give feedback to guide the system's development. StarGuide GX uses dual-sided cadmium zinc telluride detectors and a dual-collimator design meant to remove manual collimator changes. It also uses NVIDIA RTX accelerated computing for image reconstruction. The system received CE Mark in November 2025 and is on sale in select EU states. Its US Food and Drug Administration 510(k) clearance is pending.

Yahoo Finance
Oct 19th, 2026
GE HealthCare launches LOGIQ Focus ultrasound with AI tools, 26% faster scans

GE HealthCare has launched LOGIQ Focus, a new general imaging ultrasound system in its LOGIQ family. The company announced the product in Chicago on October 19, 2026. The system runs on cSound Architecture and pairs high-definition imaging with AI-enabled tools. One of them, Auto Preset Assistant, detects the anatomy being scanned and activates the matching preset, saving up to five clicks per exam. In a third-party study, 90% of participants rated its image quality as excellent. The system was 26% faster than the predicate system. LOGIQ Focus is 510(k) cleared and CE Marked. GE HealthCare expects it and several other new products to add 1% to 2% to revenue growth, following more than $5 billion in innovation investment since 2023.

Business Wire
Oct 5th, 2026
GE HealthCare to acquire SOFIE Biosciences for $945M to expand US radiopharmaceutical supply

GE HealthCare has agreed to acquire SOFIE Biosciences, a US-based contract manufacturer of PET radiopharmaceuticals, for $945 million in cash. The deal with seller Trilantic North America is expected to close in the first half of 2027, subject to regulatory approvals. SOFIE Biosciences operates 15 contract manufacturing sites with 21 cyclotrons across the US, plus a theranostics-focused development and manufacturing facility. The acquisition establishes GE HealthCare's presence in the time-critical "final mile" of US PET radiopharmaceutical supply. The PET radiopharmaceutical market is expanding rapidly with approximately 20 PET radiotracers and over 30 radiotherapeutics currently under development. SOFIE Biosciences' portfolio includes a Phase III FAPI asset for which GE HealthCare already holds non-US rights. GE HealthCare estimates the transaction will be accretive to revenue growth, earnings margin, and earnings per share in the first full year of ownership.

PR Newswire
Sep 30th, 2026
AsiaMedic first in ASEAN to deploy GE HealthCare's MR31 deep learning MRI platform

AsiaMedic has become the first site in ASEAN to implement MR31, GE HealthCare's latest generation MRI platform featuring deep learning technology. The Singapore-based imaging centre is among the earliest adopters in Asia Pacific. MR31 incorporates deep learning technologies that reduce scan times and enable detailed examinations across neurological, musculoskeletal and nerve imaging. Sonic DL for 3D delivers up to 12 times scan acceleration, reducing examination times across brain, spine, orthopaedic and body scans. The platform also supports high-quality prostate MRI imaging. AIR Recon DL Phase Correction provides improved visualisation of clinically significant lesions, whilst high-resolution T2-weighted imaging aids lesion localisation for prostate fusion biopsy planning. Shorter scan times mean reduced patient time in scanners and may help decrease repeat examinations caused by movement.

Associated Press
Sep 22nd, 2026
GE HealthCare raises quarterly dividend 14% to $0.04 per share for Q3 2026

GE HealthCare Technologies announced a 14% dividend increase for the third quarter of 2026. The company's board declared a cash dividend of $0.04 per share, up from the previous quarter. The dividend will be paid on 13 November 2026 to shareholders of record as of 23 October 2026. GE HealthCare is a global healthcare solutions provider specialising in medical technology, pharmaceutical diagnostics, and AI-enabled software solutions. The company operates a $20.6 billion business with approximately 54,000 employees worldwide, serving the healthcare industry through its Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions segments.

INACTIVE